title: Lesion-induced hippocampal plasticity in transgenic Alzheimer's disease mouse models: influences of age, genotype, and estrogen.
abstract: We have studied entorhinal cortex lesion-induced sprouting in the hippocampus in young, adult, and aged control and transgenic Alzheimer's disease model mice. The entorhinal cortex was unilaterally, partially lesioned, and four weeks later the subsequent axonal sprouting in dentate gyrus was analyzed. Our data demonstrate that young and adult, control and amyloid-beta protein precursor (AbetaPP)/presenilin 1 (PS1) mice display a significantly increased density of staining for synaptophysin in dentate gyrus, indicative of axonal sprouting. However, whereas young and adult mice demonstrate sprouting, aged mice (control and AbetaPP/PS1) do not show a significant upregulation of synaptophysin staining following the lesions. In contrast, aged mice overexpressing PS1 show an increased regenerative response compared to age-matched control mice and mice overexpressing AbetaPP which do not show sprouting. Further, the data demonstrate that a significant Abeta load in the dentate gyrus does not prevent axonal sprouting. Lastly, only aged mice show significant shrinkage of the molecular layer of dentate gyrus following entorhinal cortex lesions. Further, adult ovariectomized females (control and AbetaPP/PS1) are significantly reduced in their plasticity following lesions. Taken together, the data indicate that amyloid-beta deposits do not negatively impact plasticity in the brain and that overexpression of AbetaPP is not beneficial, but that normal estrogen levels are beneficial for plasticity.
authors: Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. ikadisha@uab.edu
authors: Inga
authors: I
authors: Kadish
authors: Thomas
authors: T
authors: van Groen
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000367:Age Factors; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics; D000818:Animals; D004195:Disease Models, Animal; D004967:Estrogens / Q000502:physiology*; D005260:Female; D007839:Functional Laterality; D005786:Gene Expression Regulation / Q000187:drug effects / Q000235:genetics; D005838:Genotype; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000293:injuries* / Q000503:physiopathology*; D006801:Humans; D007051:Ibotenic Acid / Q000633:toxicity; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009154:Mutation / Q000235:genetics; D009473:Neuronal Plasticity / Q000187:drug effects / Q000235:genetics*; D010052:Ovariectomy / Q000379:methods; D053764:Presenilin-1 / Q000235:genetics; D016708:Synaptophysin / Q000378:metabolism; D013997:Time Factors
chemical_list: D016564:Amyloid beta-Protein Precursor; D004967:Estrogens; D005904:Glial Fibrillary Acidic Protein; C508853:PSEN1 protein, human; D053764:Presenilin-1; D016708:Synaptophysin; D007051:Ibotenic Acid; D000110:Acetylcholinesterase